why choose us

First received: January 16, 2023

Clinical Trial: Manufacture of Clinical T-cell Products for Future Treatment

Study Status: Completed

Recruit Status: Completed

Condition: Virus-specific T Cells

Study Type: Observational


Official Title: Pilot Study to Manufacture Clinical T-cell Products for Future Treatment

Brief Summary: The aim of this pilot study is to validate the manufacture of T-cell products using GMP-approved reagents for future clinical use. Lymphocytes from whole blood of max 300ml from volunteers or from total 9 volunteer apheresates will be isolated to validate the protocol under Good Manufacturing Practice (GMP).

Read more